In MASLD and obesity, changes in defensin levels (such as α-defensins 5 and 6) may lead to an altered gut microbiota composition that promotes dysbiosis, systemic inflammation, and disruption of gut barrier integrity. Here, DEFA5 is linked to obesity due to melanocortin 4 receptor deficiency.